Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9216-9230
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9216
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9216
Table 1 Success of biofeedback for fecal incontinence
Ref. | Year | Patients (n) | Significant reduction in incontinence (percentage of patients) | Improvement in quality of life (percentage of patients) | Adjuncts to traditional biofeedback |
Keck et al[33] | 1994 | 15 | 73% | NR | None |
Solomon et al[28] | 2003 | 102 | 70% | 69% | Anal manometry, transanal ultrasound |
Terra et al[34] | 2006 | 239 | 60% | NR | EMG, electrostimulation |
Naimy et al[30] | 2007 | 49 | None | None | Electrostimulation |
Byrne et al[32] | 2007 | 385 | 70% | 87% | None |
Heymen et al[27] | 2009 | 45 | 76% | NR | None |
Schwandner et al[29] | 2010 | 158 | 50% | NR | EMG, electrostimulation |
Bartlett et al[26] | 2011 | 72 | 86% | 100% | None |
Jodorkovsky et al[31] | 2013 | 12 | 80% | NR | None |
Table 2 Success of overlapping sphincteroplasty
Ref. | Year | No. of patients with follow-up | Mean follow-up (mo) | Success1 (percentage of patients) |
Karoui et al[52] | 2000 | 74 | 40 | 28% |
Halverson et al[40] | 2002 | 49 | 69 | 46% |
Bravo Gutierrez et al[39] | 2004 | 130 | 120 | 41% |
Barisic et al[49] | 2006 | 65 | 80 | 48% |
Maslekar et al[55] | 2007 | 64 | 84 | 80% |
Oom et al[50] | 2009 | 120 | 111 | 60% |
Mevik et al[51] | 2009 | 25 | 84 | 53% |
Zutshi et al[53] | 2009 | 31 | 129 | 0% |
Table 3 Studies of outcomes of sacral nerve stimulation
Ref. | Year | Patients (n) | Significant reduction in incontinence scores and incontinent episodes | Significant increase in quality of life |
Leroi et al[73] | 2005 | 27 | Y | Y |
Boyle et al[63] | 2009 | 15 | Y | NR |
Brouwer et al[64] | 2010 | 55 | Y | Y |
Wexner et al[79] | 2010 | 120 | Y | Y |
Hollingshead et al[76] | 2011 | 18 | Y | NR |
Lim et al[78] | 2011 | 41 | Y | Y |
Mellgren et al[81] | 2011 | 83 | Y | Y |
George et al[77] | 2012 | 23 | Y | Y |
Devroede et al[83] | 2012 | 78 | Y | Y |
Hull et al[75] | 2013 | 76 | Y | Y |
Damon et al[82] | 2013 | 92 | Y | Y |
Table 4 Outcomes of artificial bowel sphincter
Ref. | Year | Patients (n) | Explanted devices (n) | Success (percentage of patients), intention to treat | Complications |
Lehur et al[93] | 2000 | 24 | 7 | 83% | Obstructed defecation |
Altomare et al[94] | 2001 | 28 | 3 | 75% | Obstructed defecation, infection, device erosion |
Devesa et al[95] | 2002 | 53 | 10 | 65% | Perforation, infection, sepsis, device erosion, pain, impaction |
Wong et al[97] | 2002 | 112 | 41 | 53% | Infection, pain |
Lehur et al[101] | 2002 | 16 | 4 | 69% | Erosion |
Parker et al[96] | 2003 | 45 | 18 | 49% | Infection, pain |
O’Brien et al[98] | 2004 | 14 | 1 | NR as percentage | Obstructed defecation, non-healing of wound |
Melenhorst et al[103] | 2008 | 33 | 7 | NR as percentage | Pain, perforation, infection, obstructed defecation |
Ruiz Carmona et al[99] | 2009 | 17 | 11 | 53% | Infection, erosion |
Wexner et al[90] | 2009 | 51 | 31 | NR as percentage | Infection, malfunction, erosion, pain |
Wong et al[100] | 2011 | 52 | 14 | 67% | Perforation, cuff leak |
Table 5 Outcomes of graciloplasty
Ref. | Year | Type of graciloplasty | Patients (n) | Success (percentage of patients) |
Kumar et al[114] | 1995 | Unstimulated | 9 | 100% |
Eccersley et al[113] | 1999 | Unstimulated | 8 | 100% |
Madoff et al[109] | 1999 | Stimulated | 128 | 66% |
Wexner et al[110] | 2002 | Stimulated | 115 | 62% |
Bresler et al[112] | 2002 | Stimulated | 24 | 79% |
Rongen et al[111] | 2003 | Stimulated | 200 | 72% |
Thornton et al[117] | 2004 | Stimulated | 38 | 73% |
Hassan et al[107] | 2010 | Stimulated | 31 | 71% |
Table 6 Outcomes of antegrade continence enema in incontinent adults
Table 7 Outcomes of radiofrequency energy treatments
Ref. | Year | Patients (n) | Significant improvement in incontinence scores after treatment | Significant improvement in quality of life |
Efron et al[143] | 2003 | 50 | Y | Y |
Felt-Bersma et al[147] | 2007 | 11 | Y | NR |
Takahashi-Monroy et al[142] | 2008 | 19 | Y | Y |
Lefebure et al[144] | 2008 | 15 | Y | N |
Kim et al[148] | 2009 | 8 | N | N |
Ruiz et al[145] | 2010 | 24 | Y | Y |
Abbas et al[146] | 2012 | 27 | Y | NR |
Table 8 Outcomes of dextranomer in hyaluronic acid gel for fecal incontinence
- Citation: Koughnett JAMV, Wexner SD. Current management of fecal incontinence: Choosing amongst treatment options to optimize outcomes. World J Gastroenterol 2013; 19(48): 9216-9230
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9216.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9216